SNS-032 (BMS-387032) 5mg | 99.21%
APEXBIO TECHNOLOGY LLC
SNS-032 (BMS-387032)
Search Results
SNS-032 (BMS-387032) Evaluation Sample | 99.21%
APEXBIO TECHNOLOGY LLC
SNS-032 (BMS-387032)
Etomidate 25mg | 98%
APEXBIO TECHNOLOGY LLC
General anesthetic with GABA modulatory and GABA-mimetic actions Neuroscience|GABA Receptor
More Information Supplier PageEtomidate
Etomidate 100mg | 98%
APEXBIO TECHNOLOGY LLC
General anesthetic with GABA modulatory and GABA-mimetic actions Neuroscience|GABA Receptor
More Information Supplier PageEtomidate
Etoposide 10mM (in 1mL DMSO) | 99.81%
APEXBIO TECHNOLOGY LLC
Etoposide
Etoposide 100mg | 99.81%
APEXBIO TECHNOLOGY LLC
Etoposide
SNS-032 (BMS-387032) 10mM (in 1mL DMSO) | 99.21%
APEXBIO TECHNOLOGY LLC
SNS-032 (BMS-387032)
Etomidate 5mg | 98%
APEXBIO TECHNOLOGY LLC
General anesthetic with GABA modulatory and GABA-mimetic actions Neuroscience|GABA Receptor
More Information Supplier PageEtomidate
Etomidate 10mM (in 1mL DMSO) | 98%
APEXBIO TECHNOLOGY LLC
General anesthetic with GABA modulatory and GABA-mimetic actions Neuroscience|GABA Receptor
More Information Supplier PageEtomidate
NSC 23766 100mg | 98.57%
APEXBIO TECHNOLOGY LLC
Selective inhibitor of Rac1-GEF interaction. Cell Cycle/Checkpoint|Rho
More Information Supplier PageNSC 23766
